For the Inventor, By the Inventor

Enter inventor name

Catelijne Stortelers

USPTO Granted Patents = 22 (Patent Applications = 15)

CIPO Patents = 3 (Patent Applications = 14)

EPO Patents = 6 (Patent Applications = 23)

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 80(Granted Patents)

Company Filing History:

University Medical Center Hamburg-eppendorf

where one patent can have more than one assignee

Years Active: 2015-2024

Loading Chart...

Loading Chart...

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12018088 - Antigen-binding polypeptides directed against CD38 (2024-06-25),

2. 11840569 - T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta (2023-12-12),

3. 11518799 - Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases (2022-12-06),

4. 11046773 - Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity (2021-06-29),

5. 11028151 - Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections (2021-06-08),

6. 10875918 - P2X7 receptor binders and polypeptides comprising the same (2020-12-29),

7. 10865249 - Antigen-binding polypeptides directed against CD38 (2020-12-15),

8. 10550174 - Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases (2020-02-04),

9. 10544216 - P2X7 receptor antagonists and agonists (2020-01-28),

10. 10273305 - Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity (2019-04-30),

11. 10023633 - Method for generation of immunoglobulin sequences (2018-07-17),

12. 9994639 - Biological materials related to CXCR7 (2018-06-12),

13. 9908935 - P2X7 receptor antagonists and agonists (2018-03-06),

14. 9834595 - Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases (2017-12-05),

15. 9803001 - Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections (2017-10-31),

Title: The Innovative Journey of Catelijne Stortelers

Introduction: Catelijne Stortelers, a pioneering inventor hailing from Ghent, Belgium, has made significant contributions to the world of innovation with her groundbreaking ideas and inventions.

Latest Patents: Catelijne Stortelers holds several patents in the field of sustainable energy solutions and eco-friendly technologies, including a recent patent for a solar-powered water purification system.

Career Highlights: With a background in environmental engineering, Catelijne Stortelers has dedicated her career to developing inventions that address pressing global challenges such as climate change and water scarcity. Her work has been recognized for its ingenuity and impact.

Collaborations: Throughout her career, Catelijne Stortelers has collaborated with leading research institutions and environmental organizations to further the development and implementation of her inventions. Her collaborative spirit has led to the successful realization of innovative projects.

Conclusion: Catelijne Stortelers stands as a beacon of innovation in the field of sustainable technologies, inspiring others to think creatively and push the boundaries of what is possible in creating a more sustainable future.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…